HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

corticosterone methyl oxidase I

converts corticosterone to a labile intermediate 18-hydroxycorticosterone which is then converted to aldosterone by corticosterone methyl oxidase II
Also Known As:
CMO I
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Erdman, John W: 3 articles (09/2013 - 02/2007)
2. Ford, Nikki A: 2 articles (09/2013 - 12/2008)
3. Lindshield, Brian L: 2 articles (12/2008 - 02/2007)
4. Elsen, Amy C: 1 article (09/2013)
5. Wyss, Adrian: 1 article (12/2008)
6. Lu, Chi-Hua: 1 article (12/2008)
7. King, Jennifer L: 1 article (12/2008)
8. Goralczyk, Regina: 1 article (12/2008)
9. Canene-Adams, Kirstie: 1 article (02/2007)
10. Bernhardt, Rita: 1 article (07/2006)

Related Diseases

1. Adrenogenital Syndrome
2. Disorders of Sex Development (Intersexuality)
3. Prostatic Neoplasms (Prostate Cancer)
4. Lipidoses
5. Hypoaldosteronism (Hyporeninemic Hypoaldosteronism)

Related Drugs and Biologics

1. Corticosterone
2. Leptin
3. Aldosterone Synthase (CYP11B2)
4. beta Carotene (Betacarotene)
5. 18-Hydroxycorticosterone (18 Hydroxycorticosterone)
6. Retinoids
7. Oxidoreductases
8. Insulin (Novolin)
9. Cholesterol
10. Aldosterone